Clinical trial · Observational
Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
Resource for the Study of Lung Cancer Epidemiology in North Trent
NCT00693836CI-TRIAL-00011708unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Gathering information about genetic and environmental factors from patients with lung cancer and their partners and first-degree relatives may help doctors learn more about the disease. PURPOSE: This clinical trial is looking at the patterns, causes, and control of disease in patients with lung cancer in the North Trent (England) region.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (9)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| biologic sample preservation procedure | Other | — | UNRESOLVED |
| evaluation of cancer risk factors | Procedure | — | UNRESOLVED |
| genetic linkage analysis | Genetic | — | UNRESOLVED |
| loss of heterozygosity analysis | Genetic | — | UNRESOLVED |
| medical chart review | Other | — | UNRESOLVED |
| mutation analysis | Genetic | — | UNRESOLVED |
| polymerase chain reaction | Genetic | — | UNRESOLVED |
| polymorphism analysis | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Establishment of a resource bank of high quality genomic and plasma DNA and tumor and serum samples
Secondary outcomes (2)
- measure
- Analysis of single nucleotide polymorphisms for candidate lung cancer susceptibility genes in genomic DNA samples
- measure
- Genetic changes of lung cancer in plasma DNA samples
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS:
* Patient meeting the following criteria:
* Pathologically confirmed lung cancer or planning to undergo lung cancer surgery pending pathological confirmation
* Evidence of active disease (i.e., not in remission)
* Meets 1 of the following criteria:
* 60 years of age and under
* Has a first-degree relative with lung cancer who is 60 years of age and under
* Has two or more first- or second-degree relatives with lung cancer at any age
* Control meeting the following criteria:
* Co-habiting partner of patient OR first-degree relative of patient or their partner
* 18 years of age and over
* Resides within the North Trent Cancer Network region
PATIENT CHARACTERISTICS:
* Able and willing to complete study procedures
PRIOR CONCURRENT THERAPY:
* Not specifiedReferences
Publications (0)
Data not yet available
No reference posted for this study.